Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-15

Clinical Trial Update: Apixaban in Thrombocytopenia [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial update on apixaban in patients with thrombocytopenia, including Deep Vein Thrombosis and Pulmonary Embolism, and the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eliquis (apixaban)

Snippet

Sponsor: Rushad Patell | Conditions: Deep Vein Thrombosis, Pulmonary Embolism and Thrombosis | EARLY_Phase 1 | Status: RECRUITING